MedPath

Efficacy and safety of single-session endscopic ultrasonograpy guided fine needle aspiration biopsy and endscopic retrograde cholangiopancreatography for pathological diagnosis of pancreatic mass lesion.

Not Applicable
Recruiting
Conditions
pancreatic mass lesion
Registration Number
JPRN-UMIN000004119
Lead Sponsor
Okayama University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria are as follows: Karnofsky Performance Status <50%, active infection, the patient with inaccessible papilla Vater due to altered anatomy, Bleeding tendency(platelets<50000/mm3, prothrombin time<50%), severe complication such as liver cirrhosis and heart disease, active concomitant malignancy, and the patient inappropriate for entry onto this study under the judgment of the investigator. Written informed consent is required from all patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath